{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:24:12Z","timestamp":1784064252107,"version":"3.55.0"},"reference-count":34,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The mini-pulse oral corticosteroids treatment for alopecia areata (AA) is an accessible treatment whose efficacy and adverse effects have not yet been properly described. The objective of the study was to assess the effectiveness and safety of the mini-pulse oral corticosteroids treatment in patients with AA, and to explore potential factors associated to the response in a real-world setting. An observational study of a prospective cohort to assess the effectiveness and safety of a mini-pulse dexamethasone treatment in patients with AA, who failed to improve with topical therapies, was performed. A SALT II score and other clinical and safety variables were recorded at baseline, 3, 6, 9, and 12 months. An overall significant and progressive decrease of the SALT score was found during treatment: SALT-50 response was achieved after 9 months in 51.8% of the patients. Hypothyroidism and early age of onset were predictors of the lack of response to treatment. The treatment combination with oral minoxidil showed no effect on the SALT score reduction. Dexamethasone daily and cumulative dose were associated with a higher percentage of side effects. To conclude, the mini-pulse oral corticosteroids treatment is an effective treatment for AA, although patients with an early onset of the disease and hypothyroidism may not benefit.<\/jats:p>","DOI":"10.3390\/jcm11061694","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:30:14Z","timestamp":1647811814000},"page":"1694","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3626-1558","authenticated-orcid":false,"given":"Manuel","family":"S\u00e1nchez-D\u00edaz","sequence":"first","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4035-7955","authenticated-orcid":false,"given":"Trinidad","family":"Montero-Vilchez","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahinoa","family":"Bueno-Rodriguez","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain"},{"name":"Trichology Clinic, Hospital Universitario Virgen de las Nieves, 18002 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-2113","authenticated-orcid":false,"given":"Alejandro","family":"Molina-Leyva","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4186-1435","authenticated-orcid":false,"given":"Salvador","family":"Arias-Santiago","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves, IBS Granada, 18002 Granada, Spain"},{"name":"Trichology Clinic, Hospital Universitario Virgen de las Nieves, 18002 Granada, Spain"},{"name":"Dermatology Department, School of Medicine, University of Granada, 18002 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/bjd.14497","article-title":"Alopecia areata and health-related quality of life: A systematic review and meta-analysis","volume":"175","author":"Rencz","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0010-440X(91)90045-E","article-title":"Lifetime prevalence of psychiatric disorders in patients with alopecia areata","volume":"32","author":"Popkin","year":"1991","journal-title":"Compr. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000497166","article-title":"Psychological Profile and Quality of Life of Patients with Alopecia Areata","volume":"5","author":"Cruz","year":"2019","journal-title":"Ski. Appendage Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2017.04.1142","article-title":"Alopecia areata: An appraisal of new treatment approaches and overview of current therapies","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/exd.14129","article-title":"Understanding the significance of cytokines and chemokines in the pathogenesis of alopecia areata","volume":"29","author":"Ito","year":"2020","journal-title":"Exp. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40257-014-0086-4","article-title":"Alopecia Areata: An evidence-based treatment update","volume":"15","author":"Hordinsky","year":"2014","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/ajd.12941","article-title":"Treatment of alopecia areata: An Australian expert consensus statement","volume":"60","author":"Cranwell","year":"2019","journal-title":"Australas. J. Dermatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajd.12913","article-title":"Systemic treatments for alopecia areata: A systematic review","volume":"60","author":"Lai","year":"2019","journal-title":"Australas. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/archdischild-2019-317956","article-title":"Use of oral corticosteroids in the treatment of alopecia areata","volume":"105","author":"Cowley","year":"2020","journal-title":"Arch. Dis. Child."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jaad.2018.06.064","article-title":"Methotrexate for alopecia areata: A systematic review and meta-analysis","volume":"80","author":"Phan","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/ijt.ijt_57_19","article-title":"Alopecia Areata Treated with Oral Azathioprine: A Case Series","volume":"11","author":"Saoji","year":"2019","journal-title":"Int. J. Trichol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.15489","article-title":"JAK inhibitors for alopecia areata: A systematic review and meta-analysis","volume":"33","author":"Phan","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Martinez-Lopez, A., Montero-Vilchez, T., Sierra-S\u00e1nchez, \u00c1., Molina-Leyva, A., and Arias-Santiago, S. (2020). Advanced Medical Therapies in the Management of Non-Scarring Alopecia: Areata and Androgenic Alopecia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218390"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-4362.1996.tb03281.x","article-title":"Pulsed administration of corticosteroids in the treatment of alopecia areata","volume":"35","author":"Sharma","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3889\/oamjms.2019.004","article-title":"Efficacy and Safety of Methotrexate in Combination with Mini Pulse Doses of Methylprednisolone in Severe Alopecia Areata. The Vietnamese Experience","volume":"7","author":"Van","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1346-8138.1999.tb02049.x","article-title":"Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata","volume":"26","author":"Sharma","year":"1999","journal-title":"J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000092287","article-title":"A Comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata","volume":"212","author":"Kurosawa","year":"2006","journal-title":"Dermatology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/0378-6323.148608","article-title":"Intravenous methylprednisolone pulse therapy in severe alopecia areata","volume":"81","author":"Cosgarea","year":"2015","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/ddg.12875","article-title":"Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata","volume":"15","author":"Bauer","year":"2017","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00004836-200110000-00006","article-title":"Side effects of corticosteroid therapy","volume":"33","author":"Buchman","year":"2001","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","volume":"75","author":"Olsen","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2006.05.008","article-title":"Alopecia areata: A long term follow-up study of 191 patients","volume":"55","author":"Tosti","year":"2006","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/jdv.15582","article-title":"Alopecia areata: A long-term follow-up study of 104 patients","volume":"33","author":"Lyakhovitsky","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_25","first-page":"16","article-title":"A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive non-segmental vitiligo","volume":"16","author":"Patra","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3889\/oamjms.2019.097","article-title":"The Effectiveness of Oral Mini-Pulse Methylprednisolonein\u2014The Treatment of Alopecia Areata in Vietnam","volume":"7","author":"Thi","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0190-9622(98)70009-X","article-title":"Pulse methylprednisolone therapy for severe alopecia areata: An open prospective study of 45 patients","volume":"39","author":"Friedli","year":"1998","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/1346-8138.14871","article-title":"Predictive factors of response to pulse methylprednisolone therapy in patients with alopecia areata: A follow-up study of 105 Japanese patients","volume":"46","author":"Fujii","year":"2019","journal-title":"J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4038\/cmj.v59i4.7865","article-title":"An observational study of alopecia areata in Sri Lankan adult patients","volume":"59","author":"Ranawaka","year":"2014","journal-title":"Ceylon. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e13092","DOI":"10.1111\/dth.13092","article-title":"Combined intravenous pulse and topical corticosteroid therapy for severe alopecia areata in children: Comparison of two regimens","volume":"32","author":"Lalosevic","year":"2019","journal-title":"Dermatol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2019.08.080","article-title":"Combination tofacitinib and oral minoxidil treatment for severe alopecia areata","volume":"85","author":"Wambier","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/archderm.1987.01660350088019","article-title":"Evaluation of oral minoxidil in the treatment of alopecia areata","volume":"123","author":"Rumsfield","year":"1987","journal-title":"Arch. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2020.06.1009","article-title":"Oral minoxidil treatment for hair loss: A review of efficacy and safety","volume":"84","author":"Randolph","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kamata, M., and Tada, Y. (2020). Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21051690"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/6\/1694\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:38:59Z","timestamp":1760135939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/11\/6\/1694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":34,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["jcm11061694"],"URL":"https:\/\/doi.org\/10.3390\/jcm11061694","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]}}}